3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Pancreatic Neoplasms
8
Multiple Myeloma
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Prostatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Sarcoma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Inflammation
2
Frailty
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Adenocarcinoma
2
Ventilator-Induced Lung Injury
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Postoperative Complications
1
Pancreatic Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mucositis
1
Interventions
epigallocatechin gallate
2
Ascorbic Acid
2
peflavit
1
microcrystalline cellulose
1
fisetin
1
cabozantinib
1
Temozolomide
1
Quercetin
1
Protons
1
Photons
1
Flavonoids
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Frailty
×
Ascorbic Acid
×
Clear all
NCT04553666
2026-05-07
ReFOCUS1
University of Rochester
Phase 2
Completed
24 enrolled
17 charts
NCT06068543
2026-03-06
ReFOCUS2
University of Rochester
Phase 2
Recruiting
118 enrolled